Abstracts of the 5th Cachexia Conference, Barcelona, Spain, December 5–8, 2009

Abstracts of the 5 Cachexia Conference, Barcelona, Spain, December 5–8, 2009s of the 5 Cachexia Conference, Barcelona, Spain, December 5–8, 2009 # The Author(s) 2010. This article is published with open access at Springerlink.com 001 How does the new diagnostic criteria for protein-energy wasting in chronic kidney disease compare with the ICD-10 AM definitions? Sharyn Denmeade, Lynda Moynahan, Judy D. Bauer Nutrition Services Department, The Wesley Hospital, Brisbane, Queensland, Australia; Haemodialysis Unit, The Wesley Hospital, Brisbane, Queensland, Australia; School of Human Movement Studies, University of Queensland, Brisbane, Queensland, Australia Background and aims: Malnutrition is associated with higher levels of morbidity and mortality in patients with CKD. The aim of this study was to determine the prevalence of protein-energy wasting (PEW) using new diagnostic criteria compared with ICD-10 AM definitions in patients with CKD. Methods: Forty-two patients (22 male, 20 female; mean age, 65.7 (SD 17.6)years) from a private haemodialysis unit participated. To determine PEW, four categories are assessed: biochemistry serum albumin (<38 mg/l) or serum cholesterol (<100 mg/100 ml); body mass index (BMI) <23 or total body fat <10%; muscle mass, reduced mid-arm muscle mass area; and reduced dietary intake, protein <0.8 g/kg/day or energy <100 kJ/kg/day. At least three of the four categories must be present to diagnose PEW. The ICD-10 AM definitions of malnutrition include BMI <18.5 or evidence of weight loss, decreased intake and presence of fat loss and muscle wasting. This was assessed using subjective global assessment. Dietary intake was analysed using Foodworks (version 5). Fat mass was determined using bioelectrical impedance spectroscopy. Results: Ten patients (24%) met the criteria for PEW compared to eight patients (19%) using the ICD-10 AM criteria; however, only three patients met the criteria for both definitions. Thirteen patients had low biochemistry; 14 had low BMI; 19 had low muscle mass; 21 had low intake; two had BMI <18.5; and six had evidence of weight loss, decreased dietary intake, presence of subcutaneous fat loss and muscle wasting. Time taken for the PEW diagnosis was considerably longer than ICD-10 AM. Conclusions: The new diagnostic criteria for PEW require further validation studies in patients with CKD. 002 Practice-guiding classification of cancer cachexia in palliative cancer care (PCC): clinical pilot evaluation of the SIPP assessment tool David Blum, Kenneth C. H. Fearon, Vickie E. Baracos, Rolf Oberholzer, Susanne Linder, Susanne Jaworski, Patrick Charles Stone, Lukas Radbruch, Stein Kaasa, Florian Strasser, for the European Palliative Care Research Collaborative Oncological Palliative Medicine, Oncology, Department of Internal Medicine and Palliative Care Center, Cantonal Hospital, St. Gallen, Switzerland; Clinical and Surgical Sciences, School of Clinical Sciences and Community Health, The University of Edinburgh, Royal Infirmary, Edinburgh, UK; 3 Department of Oncology, University of Alberta, Edmonton, AB, Canada; St. George’s University of London, London, UK; Department of Palliative Medicine, RWTH Aachen University, Aachen, Germany; Clinical Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Trondheim, Norway; European Palliative Care Research Collaborative (EPCRC), an EUfunded (Sixth Framework) Project Background: The understanding of mechanism and impact of cancer cachexia is evolving; a new generic definition of wasting/cachexia includes weight loss (WL) and five additional criteria. Current nutritional assessment tools identify J Cachexia Sarcopenia Muscle (2010) 1:43–128 DOI 10.1007/s13539-010-0001-7